Iridex (IRIX) Free Cash Flow Growth (1y) (2012 - 2026)
Powered by 
Analysis
Iridex (IRIX) Free Cash Flow Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -14.34% |
| 10 | Iridex | 11.85 Mn | 7.17 Mn | 4.30 Mn | 133.33% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | 133.33% |
| Apr 4, 2026 | -36.37% |
| Jan 3, 2026 | 148.00% |
| Sep 27, 2025 | 63.00% |
| Jun 28, 2025 | 73.86% |
| Mar 29, 2025 | 33.19% |
| Dec 28, 2024 | -16.79% |
| Sep 28, 2024 | -69.79% |
| Jun 29, 2024 | -6.75% |
| Mar 30, 2024 | 46.38% |
| Dec 30, 2023 | 30.52% |
| Sep 30, 2023 | 38.84% |
| Jul 1, 2023 | 54.26% |
| Apr 1, 2023 | 10.37% |
| Dec 31, 2022 | -115.26% |
| Apr 2, 2022 | -127.89% |
| Apr 3, 2021 | 872.98% |
| Sep 26, 2020 | 115.60% |
| Jun 27, 2020 | -41.83% |
| Mar 28, 2020 | 60.64% |